23 Background: We wished to delineate granulocytes' impact on the clearance of different
Introduction:

41
Humans are endowed with an immune system that protects them from a vast number of 42 infectious assaults. When dealing with many (but not all) bacterial infections, the granulocyte 43 plays a key role in the clearance of the infection.
44
With the advent of antibiotics, we have become somewhat complacent about our ability 
48
One issue not well addressed is the question of how much of the ability to cure infections 49 is due to the antibiotics and how much is due to granulocytes. While there has been an extensive 50 literature developed in many animal model systems in which the ability of an antibiotic to kill 51 bacteria at the primary infection site has been linked to the drug exposure (2, 4, 11, 12), little has 52 been done to examine this issue in vivo for the granulocytes. Indeed, the vast majority of this 53 literature has been developed in a setting in which the animals were rendered severely 54 neutropenic by cyclophosphamide.
55
In this investigation, we examined the impact of granulocytes on bacterial cell clearance 56 in a mouse thigh infection model. We looked at two common and important bacterial pathogens,
57
Pseudomonas aeruginosa and Staphylococcus aureus. 58 We also felt it important to examine the impact of bacterial burden upon the clearance of aeruginosa ATCC 27853 were used. Stocks of the microbes were stored in skim milk at -80°C.
66
The isolate was sub-cultured on blood agar plates twice before each experiment. were placed into the tissue compartment as an initial condition, which was a random variable and 101 fit as part of the modeling process.
102
Goodness of fit was determined by examining observed-predicted plots, as well as In Figure 1A , we display the colony counts at times zero, 2 and 24 hours of P. aeruginosa 
115
(CFU/g), because of attaining stationary phase (POPMAX).
116
The changes in bacterial burden for all challenges are shown in Figure 1B . 
121
As can be seen by inspection, the regression was adequately precise and was unbiased. In Figure 3A , we display the colony counts at times zero and 24 hours of S. aureus in the increase from baseline to 24 hours.
141
The changes in bacterial burden for all challenges are shown in Figure 3B . 
146
As can be seen by inspection the regression was adequately precise and was unbiased. identified, this number is not significantly different from the value identified for Pseudomonas.
155
The number of organisms that half saturate the granulocytic kill ability was 5.55 x 10 6 CFU/g.
156
This number is believable as the initial challenge of 1 x 10 6 and 3 x 10 6 CFU in Figure 3 
157
(resulting in 3.55 x 10 6 and 1.35 x 10 7 CFU/g at time zero) shows approximate net stasis at 24 158 hours.
159
Discussion:
160
In the therapy of infections, antibiotics are a crucial tool to optimize therapeutic outcome.
161
It is also clear that many people survived serious infections in the pre-antibiotic era because of The model parameters (see Tables 1 and 2 ) showed very similar rates of maximal growth infection. This should be done with a range of bacteria and different antimicrobial agents.
230
Finally, we focused on granulocytes in this investigation, but it will be increasingly important to 231 understand what other parts of the immune system add to clearance of infection. 
